The European Congress on Immunotherapies in Cancer™ is a 2-day comprehensive and interactive program focused exclusively on immunotherapies and their practical application to the management of cancer. This intensive, interactive program will provide you with a comprehensive review of key data sets that are most relevant for managing some of the most difficult-to-treat forms of cancer. The program will focus on scientific advances, recent clinical trial results that  shape current and evolving uses of these approaches, proactive methods to monitor and  mitigate treatment-related adverse events, current and emerging testing methods,  and multidisciplinary team approaches to optimize the use of immunotherapeutic strategies to treat cancer.

• Presentación de comunicaciones